Literature DB >> 11929206

Pain management after major orthopaedic surgery: current strategies and new concepts.

Raymond S Sinatra1, Jaime Torres, Arsenio M Bustos.   

Abstract

Several recently developed analgesic techniques effectively control pain after major orthopaedic surgery. Neuraxial analgesia provided by epidural and spinal administration of local anesthetics and opioids provides the highest level of pain control; however, such therapy is highly invasive and labor intensive. Neuraxial analgesia is contraindicated in patients receiving low-molecular-weight heparin. Continuous plexus and peripheral neural blockades offer excellent analgesia without the side effects associated with neuraxial and parenteral opioids. Intravenous patient-controlled analgesia allows patients to titrate analgesics in amounts proportional to perceived pain stimulus and provide improved analgesic uniformity. Oral sustained-release opioids offer superior pain control and greater convenience than short-duration agents provide. Opioid dose requirements may be reduced by coadministration of COX-2-type nonsteroidal analgesics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929206     DOI: 10.5435/00124635-200203000-00007

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  50 in total

1.  Efficacy of periarticular injection applied trough knee other than posterior capsule in simultaneous bilateral total knee arthroplasty.

Authors:  Olcay Guler; Serhat Mutlu; Mehmet Isyar; Harun Mutlu; Ahmet M Bulbul; Mahir Mahirogullari
Journal:  J Orthop       Date:  2015-06-13

Review 2.  Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.

Authors:  Martin S Angst; David R Drover
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Cochrane in CORR®: Pre-emptive and Preventive Opioids for Postoperative Pain in Adults Undergoing All Types of Surgery.

Authors:  Tahira Devji; Mohit Bhandari
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

Review 4.  General principles for treatment of femoral head fractures.

Authors:  Vincenzo Giordano; Marcos Giordano; Renato Caravellos Glória; Felipe Serrão de Souza; Paulo di Tullio; Marco Martins Lages; Hilton Augusto Koch
Journal:  J Clin Orthop Trauma       Date:  2017-07-29

5.  Trends in Pain Medication Prescriptions and Satisfaction Scores in Spine Surgery Patients at a Single Institution.

Authors:  Erik Wang; Dennis Vasquez-Montes; Deeptee Jain; Lorraine H Hutzler; Joseph A Bosco; Themistocles S Protopsaltis; Aaron J Buckland; Charla R Fischer
Journal:  Int J Spine Surg       Date:  2020-12

6.  Efficacy of multimodal pain control protocol in the setting of total hip arthroplasty.

Authors:  Kyung-Jae Lee; Byung-Woo Min; Ki-Cheor Bae; Chul-Hyun Cho; Doo-Hyun Kwon
Journal:  Clin Orthop Surg       Date:  2009-08-17

7.  [Pain management after hemorrhoidectomy. Patient-controlled analgesia vs conventional pain therapy].

Authors:  E Hancke; M Lampinski; K Suchan; K Völke
Journal:  Chirurg       Date:  2013-07       Impact factor: 0.955

Review 8.  Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative.

Authors:  Cory J Xian; Xin-Fu Zhou
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

9.  Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center.

Authors:  Aditya V Maheshwari; Yossef C Blum; Laghvendu Shekhar; Amar S Ranawat; Chitranjan S Ranawat
Journal:  Clin Orthop Relat Res       Date:  2009-02-13       Impact factor: 4.176

10.  Cost-effectiveness of intravenous acetaminophen and ketorolac in adolescents undergoing idiopathic scoliosis surgery.

Authors:  Vidya Chidambaran; Rajeev Subramanyam; Lili Ding; Senthilkumar Sadhasivam; Kristie Geisler; Bobbie Stubbeman; Peter Sturm; Viral Jain; Mark H Eckman
Journal:  Paediatr Anaesth       Date:  2018-01-29       Impact factor: 2.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.